Outcomes
|
|
|
Buprenorphine uptake/adherence |
“How often do you take it? What is the dosage? Are you taking it correctly (as prescribed)? If not, why?” “Did you run out of your prescription before getting a refill?” “Have you stopped taking Suboxone?” |
study generated (augmented by biomarkers/: urinary drug screens at the library and clinic, pharmacy pickup data from the federal CURES database, and clinic medical record data for appointment adherence) |
Substance Use |
NIDA-Modified ASSIST V2.0 [57] |
http://www.sbirtoregon.org/wp-content/uploads/Modified-ASSIST-English-pdf.pdf
|
Alcohol Use |
AUDIT-C [58] |
https://cde.drugabuse.gov/instrument/f229c68a-67ce-9a58-e040-bb89ad432be4 or https://nida.nih.gov/sites/default/files/pdf/nmassist.pdf
|
Motivation (e.g., to stop using opioids, to take buprenoprhine) |
Readiness Ruler [59] |
https://case.edu/socialwork/centerforebp/resources/readiness-ruler
|
Depression and Anxiety |
PHQ-4 [60] |
https://www.oregonpainguidance.org/app/content/uploads/2016/05/PHQ-4.pdf
|
Background
|
|
|
Childhood Trauma Experiences |
ACES [61] |
https://www.acesaware.org/wp-content/uploads/2022/07/ACE-Questionnaire-for-Adults-Identified-English-rev7.26.22.pdf
|
Social Support |
MOS Social Support Survey [62] |
https://pubmed.ncbi.nlm.nih.gov/2035047/
|
Experience with Technology |
Adapted from Dr. Garfein’s VDOT study [63] |
Garfein, et al. (2018). Tuberculosis Treatment Monitoring by Video Directly Observed Therapy in 5 Health Districts, California, USA. Emerging infectious diseases, 24(10), 1806–1815. https://doi.org/10.3201/eid2410.180459
|
Library Usage |
Questions around individuals use of the library (e.g., time spent visiting, activities at library, frequency of visits) |
study generated |
OUD Treatment Histories |
Questions eliciting information on prior pharmacological or psychological treatment of opioid use disorder (e.g., methadone, counseling) |
study generated |